CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 9 of 22

Clinical and Experimental Rheumatology

Briefs 321–360 of 849 CurrentRheuma has covered from this journal, newest publication first

Latest from Clinical and Experimental Rheumatology

All coverage, newest first

  1. Clin Exp Rheumatol

    Self-efficacy is associated with a lower probability of damage accrual in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort

    Cohort studyLupus & APS

  2. Clin Exp Rheumatol

    Pilocarpine treatment of Sjögren's syndrome curative effect of meta-analysis of randomised controlled trials

    Meta-analysisSjögren's & overlap

  3. Clin Exp Rheumatol

    Tixagevimab-cilgavimab for the prevention of COVID-19: real-world experience in patients with rheumatic diseases receiving rituximab

    Cohort studyAcross diseases

  4. Clin Exp Rheumatol

    The clinical phenotype of isolated ocular or oral dryness in Sjögren's disease

    Case-control studySjögren's & overlap

  5. Clin Exp Rheumatol

    ABO blood groups and increased risk for the development of vascular involvement in Behçet's disease

    Cohort studyVasculitis & PMR

  6. Clin Exp Rheumatol

    A single dose of anakinra for arresting familial Mediterranean fever attacks: a proof-of-concept study

    Cohort studyAutoinflammatory & rare

  7. Clin Exp Rheumatol

    Comparison of the efficacy of Janus kinase inhibitors and adalimumab in rheumatoid arthritis: a meta-analysis

    Meta-analysisRA

  8. Clin Exp Rheumatol

    Post-COVID-19 psychological condition in systemic lupus erythematosus patients: a prospective observational study

    Cohort studyLupus & APS

  9. Clin Exp Rheumatol

    Matrix metalloproteinase-12, an indicator potentially contributing to the differential diagnosis and activity assessment of retroperitoneal fibrosis

    Diagnostic or prognostic study

  10. Clin Exp Rheumatol

    Clinical value of diagnosing ischaemic stroke in patients with Takayasu's arteritis combining multiple arterial occlusion and high-grade enhancement

    Cohort studyVasculitis & PMR

  11. Clin Exp Rheumatol

    Lower circulating IGF-1 levels in fibromyalgia: meta-analysis highlighting potential pathogenic role

    Meta-analysisFibromyalgia & pain

  12. Clin Exp Rheumatol

    Nailfold videocapillaroscopy abnormalities and vascular manifestations in Behçet's syndrome

    Cross-sectional studyVasculitis & PMR

  13. Clin Exp Rheumatol

    Ultrasonographic scores and parotid histopathology in Sjögren's disease: challenges in lymphoma identification

    Diagnostic or prognostic studySjögren's & overlap

  14. Clin Exp Rheumatol

    Macrophage requirements for abatacept response in rheumatoid arthritis

    Mechanistic studyRA

  15. Clin Exp Rheumatol

    Non-negligible prevalence of focal lymphocytic sialadenitis in minor salivary glands of non-Sjögren's disease individuals

    Meta-analysisSjögren's & overlap

  16. Clin Exp Rheumatol

    Association of catechol-O-methyltransferase Val158Met polymorphism with fibromyalgia risk and FIQ scores: an updated meta-analysis

    Meta-analysisFibromyalgia & pain

  17. Clin Exp Rheumatol

    Disease activity and quality of life in patients with systemic lupus erythematosus: a validation study using the SLE-DAS

    Diagnostic or prognostic studyLupus & APS

  18. Clin Exp Rheumatol

    Sjögren's disease and systemic lupus erythematosus overlap syndrome as distinct entity at crossroads of two autoimmune disorders: clinical characterisation from two Italian reference centres for both the diseases

    Cohort studySjögren's & overlap

  19. Clin Exp Rheumatol

    The clinical characteristics of pharyngeal and laryngeal lesions in anti-MDA5-positive dermatomyositis patients

    Cohort studyMyositis

  20. Clin Exp Rheumatol

    Predictive and diagnostic biomarkers for cytomegalovirus infection in patients with rheumatic musculoskeletal diseases treated by high-dose glucocorticoid therapy: multicentre, prospective cohort study

    Cohort studyAcross diseases

  21. Clin Exp Rheumatol

    Best practice recommendations for clinical psychological interventions in patients with fibromyalgia

    Guideline or statementFibromyalgia & pain

  22. Clin Exp Rheumatol

    Thymic stromal lymphopoietin in systemic sclerosis interstitial lung disease: a pilot study

    Cross-sectional studySystemic sclerosis

  23. Clin Exp Rheumatol

    TRIM63 and Atrogin-1 are key drivers of systemic and muscle inflammation in patients with idiopathic inflammatory myopathies

    Mechanistic studyMyositis

  24. Clin Exp Rheumatol

    C-reactive protein thresholds for discriminating active disease in psoriatic arthritis may be different in early versus established disease

    Diagnostic or prognostic studySpondyloarthritis & PsA

  25. Clin Exp Rheumatol

    Field testing and clinical validation of the mSQUASH to measure physical activity in patients with Sjögren's disease

    Diagnostic or prognostic studySjögren's & overlap

  26. Clin Exp Rheumatol

    Heterogeneity of peripheral immune cell landscape in systemic lupus erythematosus patients after belimumab treatment

    Mechanistic studyLupus & APS

  27. Clin Exp Rheumatol

    Reliability of colour Doppler ultrasonography of the major salivary glands in Sjögren's disease

    Research articleSjögren's & overlap

  28. Clin Exp Rheumatol

    Survival and early outcomes following lung transplantation for interstitial lung disease associated with non-scleroderma connective tissue disease: a national cohort study

    Cohort studySystemic sclerosis

  29. Clin Exp Rheumatol

    Long-term efficacy of sarilumab on the progression of interstitial lung disease in rheumatoid arthritis: the KEIO-RA cohort and literature review

    Cohort studyRA

  30. Clin Exp Rheumatol

    RBM15, an m6A enzyme, suppresses NLRP3 inflammasome activation in rheumatoid arthritis through macrophage metabolism

    Mechanistic studyRA

  31. Clin Exp Rheumatol

    Non-steroidal anti-inflammatory drugs in psoriatic arthritis: clinical practice suggestions based on scientific evidence and expert opinion.

    Guideline or statementSpondyloarthritis & PsA

  32. Clin Exp Rheumatol

    Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)

    Cross-sectional studySystemic sclerosis

  33. Clin Exp Rheumatol

    Gastrointestinal disorders in systemic sclerosis: cluster analysis and prognosis from a French prospective cohort

    Cohort studySystemic sclerosis

  34. Clin Exp Rheumatol

    A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale

    Trial designSystemic sclerosis

  35. Clin Exp Rheumatol

    The burden and determinants of fatigue in incident and prevalent systemic sclerosis

    Cohort studySystemic sclerosis

  36. Clin Exp Rheumatol

    Different phenotypic manifestations between Brazilian and Japanese anti-MDA5 antibody-positive dermatomyositis: an international tricentric longitudinal study

    Cohort studyMyositis

  37. Clin Exp Rheumatol

    Frailty assessment in patients with systemic sclerosis

    Cross-sectional studySystemic sclerosis

  38. Clin Exp Rheumatol

    Neutrophil gelatinase-associated lipocalin levels are associated with skin thickness and metabolic syndrome features in patients with systemic sclerosis

    Cross-sectional studySystemic sclerosis

  39. Clin Exp Rheumatol

    Clinicopathological characteristics of severe aortic valve regurgitation caused by Behçet's syndrome

    Cohort studyVasculitis & PMR

  40. Clin Exp Rheumatol

    Distinct features of trisomy 8-associated autoinflammatory disease from Behçet's disease: case series and systematic review

    Meta-analysisAutoinflammatory & rare

All 849 Briefs in ExploreShowing Briefs 321–360 of 849, newest first